Lake Forest, CA, March 31, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that it has been engaged to provide its cryogenic logistics services to Roslin Cells of Edinburgh, United Kingdom in support of Roslin’s induced pluripotent stem cell (iPSC) reprogramming service.
Read More
Tags:
Frozen Shipping,
Cancer,
frozen shipping solution,
Cold Chain Logistics,
Press Releases,
Dry Shipper,
News,
Roslin,
iPSC,
pluripotent stem cell,
reprogramming
IRVINE, California, and LAKE FOREST, California, March XX, 2015 – CombiMatrix Corporation (NASDAQ: CBMX) and Cryoport, Inc. (OTCBB: CYRX), today announced CombiMatrix has selected Cryoport as its cryogenic logistics partner for the distribution of its new CombiPGS™ genetic screening test.
Read More
Tags:
Frozen Shipping,
Cancer,
frozen shipping solution,
Cold Chain Logistics,
Press Releases,
Dry Shipper,
News,
Combimatrix
Lake Forest, CA, March 18, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that the Company introduced a new tamper-proof lock on its Cryoport Express® Shippers for exclusive use in the global animal husbandry market.
Read More
Tags:
Frozen Shipping,
Tamper-proof lock,
frozen shipping solution,
Cold Chain Logistics,
Press Releases,
Dry Shipper,
News
Lake Forest, CA, March 11, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that it is co-sponsoring the Alliance for Regenerative Medicine 3rd Annual REGENMED Investor Day, to be held March 25, 2015 at the Metropolitan Club in New York City.
Read More
Tags:
Frozen Shipping,
frozen shipping solution,
Alliance for Regenerative Medicine,
Cold Chain Logistics,
Press Releases,
Dry Shipper,
News
LAKE FOREST, CA – March 5, 2015 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that Broekman Logistics will support Cyroport’s Operations Center in Singapore, responding to Cryoport’s rapidly expanding client base in Asia. Broekman currently supports Cryoport’s European Operations Center, ensuring a seamless faciliation of Cryoport’s solutions for global life sciences clients.
Read More
Tags:
Frozen Shipping,
Broekman,
frozen shipping solution,
Cold Chain Logistics,
Press Releases,
Dry Shipper,
News
Lake Forest, CA, March 3, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced the expansion of its relationship with Fred Hutchinson Cancer Research Centers’ (“Fred Hutch”) Clinical Research Division with the inclusion of additional labs to be supported by Cryoport’s validated cryogenic logistics solutions for its cell-based therapies.
Read More
Tags:
Frozen Shipping,
Cancer,
Fred Hutchinson Cancer Research Center,
frozen shipping solution,
Cold Chain Logistics,
Press Releases,
Dry Shipper,
News
Lake Forest, CA, February 23, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that the Company is enhancing its cryogenic logistics support of its Sanaria partnership, which includes Sanaria’s production of malaria vaccine as well as its research and development efforts.
Read More
Tags:
Frozen Shipping,
Sanaria,
malaria,
vaccine,
frozen shipping solution,
Cold Chain Logistics,
Press Releases,
Dry Shipper,
News
Lake Forest, CA, February 17, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced the launch of a new logistics service supporting complete facility relocation of critical cryogenically frozen sample collections.
Read More
Tags:
Frozen Shipping,
Lab,
Clinic,
Relocation,
frozen shipping solution,
Cold Chain Logistics,
Press Releases,
Dry Shipper,
News
Lake Forest, CA, February 10, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced it has initiated support of the growing in-vitro fertilization (“IVF”) market in Nepal.
Read More
Tags:
Frozen Shipping,
IVF,
Nepal,
frozen shipping solution,
Cold Chain Logistics,
Press Releases,
Dry Shipper,
News
